AstraZeneca is committed to pushing new boundaries in Oncology therapy and delivering medicines to broaden the therapeutic options available to cancer patients and make a meaningful difference to their lives.
At present there is no donated content from this sponsor.
ESMO only accepts content from third parties after careful evaluation of its educational and scientific relevance to the ESMO target audience. Eligible material should meet the essential criterion of non-promotional intent. Such material may be published in other resources, but the content donor has given permission to ESMO for use in OncologyPRO.